New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
10:55 EDTACAD, ACAD, ATTU, ATTU, CODE, CODE, AERI, AERI, EGAN, EGAN, IMAX, IMAX, SPNS, SPNS, JAKK, JAKK, CNAT, CNAT, BIRT, BIRT, BDSI, BDSI, PERI, PERIRoth Capital to hold a conference
26th Annual Growth Stock Conference is being held in Dana Point, California on March 9-12 with webcasted company presentations to begin on March 10 at 11 am; not all company presentations may be webcasted. Webcast Link
News For ACAD;BDSI;BIRT;CNAT;JAKK;SPNS;IMAX;EGAN;AERI;CODE;ATTU;PERI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 27, 2015
09:37 EDTBDSIActive equity options trading on open
Subscribe for More Information
March 26, 2015
15:16 EDTCNATConatus price target raised to $9 from $6 at Piper Jaffray
13:46 EDTBDSIBioDelivery Sciences volatility elevated
BioDelivery Sciences April call option implied volatility is at 126, May is at 101, June is at 82; compared to its 26-week average of 78 according to Track Data, suggesting large near term price movement.
09:23 EDTCNATOn The Fly: Pre-market Movers
Subscribe for More Information
07:15 EDTCNATConatus says NAFLD/NASH Emricasan trial met primary endpoint
Subscribe for More Information
March 25, 2015
10:00 EDTAERIOn The Fly: Analyst Initiation Summary
Subscribe for More Information
March 24, 2015
16:06 EDTAERIAerie Pharmaceuticals initiated with a Buy at Brean Capital
Subscribe for More Information
06:02 EDTAERIAerie Pharmaceuticals completes enrollment for Phase 3 trial of Rhopressa
Aerie Pharmaceuticals announced the completion of enrollment in the Company’s second Phase 3 registration trial of Rhopressa, a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure,or IOP, in patients with glaucoma or ocular hypertension. Rocket 2 will measure efficacy over three months, as well as safety over one year. The primary efficacy endpoint of the trial is to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol.
March 23, 2015
16:05 EDTCNATConatus, Sigma-Aldrich present Emricasan preclinical safety results
Subscribe for More Information
March 20, 2015
15:16 EDTBDSIBioDelivery Sciences April volatility elevated
Subscribe for More Information
March 19, 2015
07:23 EDTIMAXEvercore ISI to hold a tour
Subscribe for More Information
March 17, 2015
10:23 EDTCNATConatus management to meet with JMP Securities
Meeting to be held in Denver on March 17 hosted by JMP Securities.
10:13 EDTACADOptions with decreasing implied volatility
Subscribe for More Information
09:25 EDTBDSIOn The Fly: Pre-market Movers
Subscribe for More Information
06:01 EDTACADStocks with implied volatility below IV index mean; PNK ACAD
Subscribe for More Information
March 16, 2015
19:00 EDTBDSIOn The Fly: After Hours Movers
Subscribe for More Information
16:12 EDTBDSIBioDelivery Sciences reports Q4 EPS (51c), consensus (33c)
Subscribe for More Information
11:45 EDTPERIPerion Network management to meet with Benchmark Co.
Meetings to be held in Boston on March 17 and in New York on March 18 hosted by Benchmark Co.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use